Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

The molecular journey from ductal carcinoma in situ to invasive breast cancer.

Wiechmann L, Kuerer HM.

Cancer. 2008 May 15;112(10):2130-42. doi: 10.1002/cncr.23430. Review.

2.

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

3.

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.

Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F.

Mol Oncol. 2010 Aug;4(4):357-68. doi: 10.1016/j.molonc.2010.06.007. Epub 2010 Jun 26.

4.

Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast.

Amari M, Moriya T, Ishida T, Harada Y, Ohnuki K, Takeda M, Sasano H, Horii A, Ohuchi N.

Jpn J Clin Oncol. 2003 Nov;33(11):556-62.

PMID:
14711979
5.

Biology of ductal carcinoma in situ classification based on biologic potential.

Tsikitis VL, Chung MA.

Am J Clin Oncol. 2006 Jun;29(3):305-10. Review.

PMID:
16755185
7.

Classification of ductal carcinoma in situ by gene expression profiling.

Hannemann J, Velds A, Halfwerk JB, Kreike B, Peterse JL, van de Vijver MJ.

Breast Cancer Res. 2006;8(5):R61.

8.

Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.

Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, Done SJ.

Clin Cancer Res. 2008 Jul 15;14(14):4446-54. doi: 10.1158/1078-0432.CCR-07-4960.

9.

The natural history of ductal carcinoma in situ of the breast: a review.

Erbas B, Provenzano E, Armes J, Gertig D.

Breast Cancer Res Treat. 2006 May;97(2):135-44. Epub 2005 Dec 1. Review.

PMID:
16319971
10.

Progression of heterogeneous breast tumors.

Subramanian B, Axelrod DE.

J Theor Biol. 2001 May 7;210(1):107-19.

PMID:
11343435
12.
13.

Telomerase activity in ductal carcinoma in situ of the breast.

Shpitz B, Zimlichman S, Zemer R, Bomstein Y, Zehavi T, Liverant S, Bernehim J, Kaufman Z, Klein E, Shapira Y, Klein A.

Breast Cancer Res Treat. 1999 Nov;58(1):65-9.

PMID:
10634519
14.

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR.

Am J Surg Pathol. 2005 Jun;29(6):734-46.

PMID:
15897740
15.

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.

Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D.

Clin Cancer Res. 2008 Jan 15;14(2):370-8. doi: 10.1158/1078-0432.CCR-07-1127.

16.

A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena.

Kopans DB, Rafferty E, Georgian-Smith D, Yeh E, D'Alessandro H, Moore R, Hughes K, Halpern E.

Cancer. 2003 Jun 15;97(12):2951-9.

17.

Current controversies in the treatment of ductal carcinoma in situ of the breast.

Franceschini G, Terribile D, Magno S, Fabbri C, D'Alba P, Chiesa F, Di Leone A, Scafetta I, Masetti R.

Ann Ital Chir. 2008 May-Jun;79(3):151-5. Review.

PMID:
18958961
18.

Prognostic and predictive molecular markers in DCIS: a review.

Nofech-Mozes S, Spayne J, Rakovitch E, Hanna W.

Adv Anat Pathol. 2005 Sep;12(5):256-64. Review.

PMID:
16210921
19.

Molecular markers and therapeutic targets in ductal carcinoma in situ.

Boland GP, Knox WF, Bundred NJ.

Microsc Res Tech. 2002 Oct 1;59(1):3-11. Review.

PMID:
12242692
20.

Biology and treatment of ductal carcinoma in situ.

Irvine T, Fentiman IS.

Expert Rev Anticancer Ther. 2007 Feb;7(2):135-45. Review.

PMID:
17288525

Supplemental Content

Support Center